{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:33:27Z","timestamp":1779917607303,"version":"3.53.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vaccine.2014.08.003","type":"journal-article","created":{"date-parts":[[2014,8,17]],"date-time":"2014-08-17T13:30:16Z","timestamp":1408282216000},"page":"5614-5623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Novel G3\/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine"],"prefix":"10.1016","volume":"32","author":[{"given":"Carolien E.","family":"van de Sandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost H.C.M.","family":"Kreijtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina M.","family":"Geelhoed-Mieras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella E. Vogelzang-van","family":"Trierum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nella J.","family":"Nieuwkoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.M.C.","family":"van de Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron A.M.","family":"Fouchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bror","family":"Morein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus F.","family":"Rimmelzwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.08.003_bib0005","series-title":"Influenza (seasonal) fact sheet No. 211","author":"WHO","year":"2014"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.003_bib0010","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines","volume":"59","author":"Cox","year":"2004","journal-title":"Scand J Immunol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2014.08.003_bib0015","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/S0264-410X(01)00471-6","article-title":"Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis","volume":"20","author":"Beyer","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2014.08.003_bib0020","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/jinf.2000.0652","article-title":"Influenza virus: a master of metamorphosis","volume":"40","author":"De Jong","year":"2000","journal-title":"J Infect"},{"issue":"6161","key":"10.1016\/j.vaccine.2014.08.003_bib0025","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1126\/science.1244730","article-title":"Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution","volume":"342","author":"Koel","year":"2013","journal-title":"Science"},{"issue":"7195","key":"10.1016\/j.vaccine.2014.08.003_bib0030","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nature06945","article-title":"The genomic and epidemiological dynamics of human influenza A virus","volume":"453","author":"Rambaut","year":"2008","journal-title":"Nature"},{"issue":"5682","key":"10.1016\/j.vaccine.2014.08.003_bib0035","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2014.08.003_bib0040","doi-asserted-by":"publisher","first-page":"D31","DOI":"10.1016\/j.vaccine.2008.07.078","article-title":"Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses","volume":"26","author":"Russell","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.003_bib0045","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C","article-title":"Mismatch between the 1997\/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly","volume":"61","author":"de Jong","year":"2000","journal-title":"J Med Virol"},{"issue":"7201","key":"10.1016\/j.vaccine.2014.08.003_bib0050","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/454160a","article-title":"The contents of the syringe","volume":"454","author":"Salzberg","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.08.003_bib0055","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1146\/annurev.iy.08.040190.003513","article-title":"Structural basis of immune recognition of influenza virus hemagglutinin","volume":"8","author":"Wilson","year":"1990","journal-title":"Annu Rev Immunol"},{"issue":"6044","key":"10.1016\/j.vaccine.2014.08.003_bib0060","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.vaccine.2014.08.003_bib0065","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1128\/JVI.03509-12","article-title":"H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice","volume":"87","author":"Margine","year":"2013","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2014.08.003_bib0070","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1128\/JVI.01035-10","article-title":"Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets","volume":"84","author":"Bosch","year":"2010","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2014.08.003_bib0075","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1086\/381123","article-title":"Protection of mice with recombinant influenza virus neuraminidase","volume":"189","author":"Kilbourne","year":"2004","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2014.08.003_bib0080","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2014.08.003_bib0085","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1073\/pnas.82.6.1785","article-title":"A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes","volume":"82","author":"Yewdell","year":"1985","journal-title":"Proc Nat Acad Sci USA"},{"issue":"24","key":"10.1016\/j.vaccine.2014.08.003_bib0090","doi-asserted-by":"publisher","first-page":"12241","DOI":"10.1128\/JVI.01563-08","article-title":"Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans","volume":"82","author":"Assarsson","year":"2008","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2014.08.003_bib0095","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1128\/JVI.72.11.8682-8689.1998","article-title":"Human cytotoxic T-lymphocyte repertoire to influenza A viruses","volume":"72","author":"Jameson","year":"1998","journal-title":"J Virol"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2014.08.003_bib0100","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1099\/vir.0.048652-0","article-title":"Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses","volume":"94","author":"Hillaire","year":"2013","journal-title":"J Gen Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2014.08.003_bib0105","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1128\/JVI.02694-07","article-title":"Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus","volume":"82","author":"Kreijtz","year":"2008","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2014.08.003_bib0110","first-page":"3478","article-title":"Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals","volume":"118","author":"Lee","year":"2008","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2014.08.003_bib0115","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1128\/JVI.02843-13","article-title":"Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus","volume":"88","author":"van de Sandt","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.003_bib0120","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/viro.1998.9521","article-title":"Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues","volume":"254","author":"Nguyen","year":"1999","journal-title":"Virology"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2014.08.003_bib0125","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1099\/0022-1317-82-11-2697","article-title":"Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection","volume":"82","author":"Heinen","year":"2001","journal-title":"J Gen Virol"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2014.08.003_bib0130","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1099\/0022-1317-81-11-2689","article-title":"Heterologous protection against lethal A\/HongKong\/156\/97 (H5N1) influenza virus infection in C57BL\/6 mice","volume":"81","author":"O\u2018Neill","year":"2000","journal-title":"J Gen Virol"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2014.08.003_bib0135","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1099\/vir.0.033076-0","article-title":"Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells","volume":"92","author":"Hillaire","year":"2011","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2014.08.003_bib0140","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.vaccine.2006.08.036","article-title":"Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice","volume":"25","author":"Kreijtz","year":"2007","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2014.08.003_bib0145","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1016\/j.vaccine.2009.05.079","article-title":"Infection of mice with a human influenza A\/H3N2 virus induces protective immunity against lethal infection with influenza A\/H5N1 virus","volume":"27","author":"Kreijtz","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2014.08.003_bib0150","doi-asserted-by":"publisher","first-page":"e1002381","DOI":"10.1371\/journal.ppat.1002381","article-title":"Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates","volume":"7","author":"Weinfurter","year":"2011","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.vaccine.2014.08.003_bib0155","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.vaccine.2014.08.003_bib0160","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.4049\/jimmunol.162.12.7578","article-title":"Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species","volume":"162","author":"Jameson","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.003_bib0165","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.003_bib0170","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/498980","article-title":"Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature","volume":"193","author":"Epstein","year":"2006","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2014.08.003_bib0175","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/infdis\/jir436","article-title":"Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children","volume":"204","author":"Hoft","year":"2011","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2014.08.003_bib0180","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/(SICI)1096-9071(199610)50:2<105::AID-JMV1>3.0.CO;2-E","article-title":"T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine","volume":"50","author":"Mbawuike","year":"1996","journal-title":"J Med Virol"},{"issue":"6269","key":"10.1016\/j.vaccine.2014.08.003_bib0185","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/344873a0","article-title":"Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs","volume":"344","author":"Takahashi","year":"1990","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2014.08.003_bib0190","first-page":"317","article-title":"Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route","volume":"72","author":"Mowat","year":"1991","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2014.08.003_bib0195","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1006\/cimm.2001.1835","article-title":"Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function","volume":"211","author":"Sambhara","year":"2001","journal-title":"Cell Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2014.08.003_bib0200","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1086\/515285","article-title":"Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes","volume":"177","author":"Sambhara","year":"1998","journal-title":"J Infect Dis"},{"issue":"20\u201321","key":"10.1016\/j.vaccine.2014.08.003_bib0205","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1016\/S0264-410X(99)00063-8","article-title":"Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine","volume":"17","author":"Rimmelzwaan","year":"1999","journal-title":"Vaccine"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2014.08.003_bib0210","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1099\/0022-1317-78-4-757","article-title":"Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines","volume":"78","author":"Rimmelzwaan","year":"1997","journal-title":"J Gen Virol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2014.08.003_bib0215","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S0264-410X(00)00310-8","article-title":"A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines","volume":"19","author":"Rimmelzwaan","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.08.003_bib0220","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.vaccine.2004.05.013","article-title":"Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia","volume":"23","author":"Frazer","year":"2004","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2014.08.003_bib0225","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.1073\/pnas.0403572101","article-title":"Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans","volume":"101","author":"Davis","year":"2004","journal-title":"Proc Nat Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.003_bib0230","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1006\/cimm.1997.1088","article-title":"Iscoms containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses","volume":"177","author":"Sjolander","year":"1997","journal-title":"Cell Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2014.08.003_bib0235","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1128\/JVI.73.4.3292-3300.1999","article-title":"Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance","volume":"73","author":"Verschoor","year":"1999","journal-title":"J Virol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2014.08.003_bib0240","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0264-410X(98)80125-4","article-title":"Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines","volume":"16","author":"Coulter","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.003_bib0245","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1084\/jem.176.1.119","article-title":"Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition","volume":"176","author":"van Binnendijk","year":"1992","journal-title":"J Exp Med"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2014.08.003_bib0250","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0264-410X(00)00179-1","article-title":"Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8(+) cytotoxic T lymphocytes","volume":"19","author":"Voeten","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.08.003_bib0255","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cbi.2008.01.008","article-title":"Immune up regulatory response of a non-caloric natural sweetener, stevioside","volume":"173","author":"Sehar","year":"2008","journal-title":"Chem Biol Interact"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.003_bib0260","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0166-0934(98)00071-8","article-title":"Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro","volume":"74","author":"Rimmelzwaan","year":"1998","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2014.08.003_bib0265","first-page":"25","volume":"1975","author":"Palmer","year":"1975"},{"issue":"3","key":"10.1016\/j.vaccine.2014.08.003_bib0270","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/JCM.12.3.426-432.1980","article-title":"Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement","volume":"12","author":"Frank","year":"1980","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2014.08.003_bib0275","doi-asserted-by":"publisher","first-page":"e5538","DOI":"10.1371\/journal.pone.0005538","article-title":"Vaccination against human influenza A\/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A\/H5N1 virus","volume":"4","author":"Bodewes","year":"2009","journal-title":"PLoS One"},{"issue":"49","key":"10.1016\/j.vaccine.2014.08.003_bib0280","doi-asserted-by":"publisher","first-page":"6833","DOI":"10.1016\/j.vaccine.2009.09.015","article-title":"The novel adjuvant CoVaccineHT increases the immunogenicity of cell-culture derived influenza A\/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro","volume":"27","author":"Bodewes","year":"2009","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2014.08.003_bib0285","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1128\/JVI.74.15.6800-6807.2000","article-title":"Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes","volume":"74","author":"Voeten","year":"2000","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.003_bib0290","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4049\/jimmunol.1004114","article-title":"ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells","volume":"187","author":"Duewell","year":"2011","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2014.08.003_bib0295","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1440-1711.1998.00756.x","article-title":"Functional aspects of iscoms","volume":"76","author":"Morein","year":"1998","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2014.08.003_bib0300","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4049\/jimmunol.1203483","article-title":"Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination","volume":"191","author":"Bonduelle","year":"2013","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2014.08.003_bib0305","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.humimm.2011.03.001","article-title":"Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin","volume":"72","author":"Basha","year":"2011","journal-title":"Hum Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2014.08.003_bib0310","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S1473-3099(09)70263-4","article-title":"Yearly influenza vaccinations: a double-edged sword?","volume":"9","author":"Bodewes","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.003_bib0315","doi-asserted-by":"publisher","first-page":"e1000745","DOI":"10.1371\/journal.ppat.1000745","article-title":"Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines","volume":"6","author":"Manicassamy","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2014.08.003_bib0320","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ncomms1026","article-title":"Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus","volume":"1","author":"Medina","year":"2010","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.vaccine.2014.08.003_bib0325","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.4049\/jimmunol.1000091","article-title":"Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus","volume":"185","author":"Skountzou","year":"2010","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2014.08.003_bib0330","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3201\/eid1110.050644","article-title":"Evolution of H5N1 avian influenza viruses in Asia","volume":"11","author":"WHO","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2014.08.003_bib0335","doi-asserted-by":"publisher","first-page":"792","DOI":"10.4161\/hv.6.10.12915","article-title":"Pre-pandemic and pandemic influenza vaccines","volume":"6","author":"Rockman","year":"2010","journal-title":"Hum Vaccin"},{"issue":"2","key":"10.1016\/j.vaccine.2014.08.003_bib0340","doi-asserted-by":"publisher","first-page":"L108","DOI":"10.1152\/ajplung.00105.2013","article-title":"Adapting global influenza management strategies to address emerging viruses","volume":"305","author":"Noah","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.vaccine.2014.08.003_bib0345","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2334-13-81","article-title":"Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis","volume":"13","author":"Kelso","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2014.08.003_bib0350","doi-asserted-by":"publisher","first-page":"B40","DOI":"10.1016\/S0264-410X(02)00509-1","article-title":"Selection of influenza vaccine strains and developing pandemic vaccines","volume":"20","author":"Wood","year":"2002","journal-title":"Vaccine"},{"issue":"6088","key":"10.1016\/j.vaccine.2014.08.003_bib0355","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"Herfst","year":"2012","journal-title":"Science"},{"issue":"7468","key":"10.1016\/j.vaccine.2014.08.003_bib0360","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature12476","article-title":"Limited airborne transmission of H7N9 influenza A virus between ferrets","volume":"501","author":"Richard","year":"2013","journal-title":"Nature"},{"issue":"7403","key":"10.1016\/j.vaccine.2014.08.003_bib0365","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature10831","article-title":"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA\/H1N1 virus in ferrets","volume":"486","author":"Imai","year":"2012","journal-title":"Nature"},{"issue":"6142","key":"10.1016\/j.vaccine.2014.08.003_bib0370","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1126\/science.1239844","article-title":"Infectivity, transmission, and pathology of human H7N9 influenza in ferrets and pigs","volume":"341","author":"Zhu","year":"2013","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14011165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14011165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T02:51:57Z","timestamp":1689475917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14011165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":74,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0264410X14011165"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel G3\/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}